Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IFIH1 Antibodies:
anti-Mouse (Murine) IFIH1 Antibodies:
anti-Rat (Rattus) IFIH1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal IFIH1 Primary Antibody for IHC (p), IHC - ABIN257906
de Koning, Rodijk-Olthuis, van Vlijmen-Willems, Joosten, Netea, Schalkwijk, Zeeuwen: A comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: upregulation of dectin-1 in psoriasis. in The Journal of investigative dermatology 2010
Show all 8 Pubmed References
Human Polyclonal IFIH1 Primary Antibody for IHC, ELISA - ABIN1002835
Hiscott, Nguyen, Arguello, Nakhaei, Paz: Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. in Oncogene 2006
Show all 4 Pubmed References
Human Polyclonal IFIH1 Primary Antibody for IHC, ELISA - ABIN1002836
Kang, Gopalkrishnan, Lin, Randolph, Valerie, Pestka, Fisher: Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. in Oncogene 2004
Show all 4 Pubmed References
Human Polyclonal IFIH1 Primary Antibody for IHC, ELISA - ABIN185002
Kang, Gopalkrishnan, Wu, Jankowsky, Pyle, Fisher: mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. in Proceedings of the National Academy of Sciences of the United States of America 2002
Show all 4 Pubmed References
Mouse (Murine) Polyclonal IFIH1 Primary Antibody for ELISA - ABIN253294
Kato, Takeuchi, Sato, Yoneyama, Yamamoto, Matsui, Uematsu, Jung, Kawai, Ishii, Yamaguchi, Otsu, Tsujimura, Koh, Reis e Sousa, Matsuura, Fujita, Akira: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. in Nature 2006
Mouse (Murine) Polyclonal IFIH1 Primary Antibody for IHC, WB - ABIN1169452
Kovacsovics, Martinon, Micheau, Bodmer, Hofmann, Tschopp: Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation. in Current biology : CB 2002
These findings indicate that human parainfluenza virus type 2 V binding to MDA5 is important for HPIV-2 virulence in nonhuman primates and that some V protein residues involved in MDA5 binding are not essential for efficient HPIV-2 growth in vitro.
study revealed that encapsidation of DI-RNA (defective interfering genomes) molecules within the measles virus nucleocapsid abolished their immunoactive properties. identified specific interactions of DI-RNAs with both RIG-I (show DDX58 Antibodies) and LGP2 (show DHX58 Antibodies) but not MDA5.
An up-regulation of type I IFN-induced gene transcripts in all 5 patients tested and a heterozygous gain-of-function mutation in IFIH1 in each family were discovered in families with a Singleton-Merten syndrome phenotype.
Data indicate autosomal recessive, homozygous MDA5 encoding gene IFIH1 mutation in the proband, and both parents and a brother were carriers of this mutation.
this study shows that PACT (show RBBP6 Antibodies) facilitates RNA-induced formation of MDA5 oligomers in response to viruses
Human peripheral blood mononuclear cells (PBMCs) and cell lines expressing the risk variant IFIH1(T946) exhibited heightened basal and ligand-triggered production of type I interferons.
Mechanistically, West Nile virus NS1 (show PTPN11 Antibodies) targets RIG-I (show DDX58 Antibodies) and melanoma differentiation-associated gene 5 (MDA5) by interacting with them and subsequently causing their degradation by the proteasome.
The rare variant rs35667974, encoding an Ile923Val amino acid change in the IFIH1 gene protein product, is protective for psoriatic arthritis.
This would suggest that the change in IP-10 (show CXCL10 Antibodies) is genotypically driven, while the change in IL-6 (show IL6 Antibodies) may be reflective of systemic lupus erythematosus (SLE) transition status. These data suggest that IFIH1 may contribute to SLE pathogenesis via altered inflammatory mechanisms.
dynamic sumoylation and desumoylation of MDA5 and RIG-I (show DDX58 Antibodies) modulate efficient innate immunity to RNA virus and its timely termination.
GPATCH3 negatively regulates both RIG-I (show DDX58 Antibodies)- and MDA5-mediated signaling.
These findings imply that MDA5-induced cell death and inflammation in the pancreas facilitate progression to autoimmune destruction of pancreatic beta-cells.
Mice with a knock-in mutation encoding IFIH1(T946) displayed enhanced basal expression of type I interferons, survived a lethal viral challenge and exhibited increased penetrance in autoimmune models, including a combinatorial effect with other risk variants. Furthermore, IFIH1(T946) mice manifested an embryonic survival defect consistent with enhanced responsiveness to RNA self ligands.
TRIM65 as an essential component for the MDA5 signaling pathway and provide physiological evidence showing that ubiquitination is important for MDA5 oligomerization and activation.
MDA-5 stimulation leads to endothelial dysfunction.
The p150 (show ABL1 Antibodies) isoform of ADAR1 (show ADAR Antibodies) uniquely regulated the MDA5 pathway.
MDA5, detects viral RNA and triggers induction of type I interferons, chemical messengers that induce inflammation and help regulate the immune responses.
Duox2 (show DUOX1 Antibodies)-derived reactive oxygen species are necessary for the innate immune response and trigger the induction of RIG-I (show DDX58 Antibodies) and MDA5 to resist influenza A infection in human nasal epithelium and mouse nasal mucosa.
L region antisense RNA of EMCV is a key determinant of innate immunity to the virus and represents an RNA that activates LGP2 (show DHX58 Antibodies) associated MDA5 in virally-infected cells.
embryonic death and phenotypes of Adar1 (show ADAR Antibodies)(E861A/E861A) were rescued by concurrent deletion of the cytosolic sensor of dsRNA, MDA5.
IFIH1 heterozygous mice have a regulatory rather than effector T-cell response at the site of autoimmunity, supporting IFIH1 expression as an essential regulator of the diabetogenic T-cell response.
study identifies the porcine 2'-5'-oligoadenylate synthetase-like protein (pOASL) as an interferon (show IFNA Antibodies) (IFN)-stimulated gene (ISG) against classical swine fever virus (CSFV); show that pOASL, as an MDA5-interacting protein, is a coactivator of MDA5-mediated IFN induction to exert anti-CSFV actions
These data indicate that classical swine fever virus can be recognized by both RIG-I (show DDX58 Antibodies) and MDA5 to initiate the RIG-I (show DDX58 Antibodies) signaling pathway to trigger innate defenses against infection.
crystal structure of the MDA5 ATP-hydrolysis domain in complex with parainfluenzavirus 5 V protein; the V protein unfolded the ATP-hydrolysis domain of MDA5 and recognized a structural motif of MDA5 normally buried in the helicase (show DNA2 Antibodies) fold leading to disruption of MDA5 ATP-hydrolysis site and prevention of RNA-bound MDA5 filament formation
IFIH1 had only one nonsynonymous SNP in the helicase (show DNA2 Antibodies) domain.
DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein that is upregulated in response to treatment with beta-interferon and a protein kinase C-activating compound, mezerein. Irreversible reprogramming of melanomas can be achieved by treatment with both these agents\; treatment with either agent alone only achieves reversible differentiation. Genetic variation in this gene is associated with diabetes mellitus insulin-dependent type 19.
interferon-induced helicase C domain-containing protein 1
, melanoma differentiation associated protein-5
, melanoma differentiation-associated protein 5
, CADM-140 autoantigen
, DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide
, RIG-I-like receptor 2
, RNA helicase-DEAD box protein 116
, clinically amyopathic dermatomyositis autoantigen 140 kDa
, helicase with 2 CARD domains
, murabutide down-regulated protein
, interferon induced with helicase C domain protein 1
, melanoma differentiation associated protein 5